← Leaderboards
Qingcheng Mao
University Of Washington
$5,491,198
Attributed
$6,149,226
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2006–23$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$6,149,226 · 6
By mechanism
P01$3,908,435 · 3
R01$2,240,791 · 2
P50$0 · 1
Top collaborators
- Vera Lucia Lanchote3 shared
- Jashvant D Unadkat3 shared
Most similar at University Of Washington
Same institution · by research overlap
- Jashvant D Unadkat$14,909,800
- Vera Lucia Lanchote$883,829
- Gail Anderson$2,069,829
- Walter E Stamm$7,096,268
- Allan Edward Rettie$24,434,501
Others in their field
Top investigators on “Drug Kinetics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$241,865,009
- Sharon A Nachman · Johns Hopkins University$194,646,762
- Carol Nesel · Westat$147,274,423
- Barbara Driver · Westat, Inc.$103,746,400
- Ronald T Mitsuyasu · University Of California Los Angeles$99,239,507
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,714,869
Research focus
Drug KineticsCellsIn VitroPharmaceutical PreparationsLiverPlasmaAbcg2 GenePlacentaPregnancyFetusPregnant WomenIn VivoIntestinesDesignEstradiolEthicsExposure ToPregnantRodentFetalAbcb1 GeneBrainDrug InteractionsTissues
Grant awards (19)
Understanding Fetal Exposure to Cannabinoids Through In Vitro and In Vivo Studies$452,691
P01 · FY2023 · DA · contact PI
Understanding Fetal Exposure to Cannabinoids Through In Vitro and In Vivo Studies$448,111
P01 · FY2022 · DA · contact PI
A Systems Pharmacology approach to predict the effects of pregnancy and infectious diseases on transporter-mediated drug disposition$435,877
R01 · FY2022 · HD
A Systems Pharmacology approach to predict the effects of pregnancy and infectious diseases on transporter-mediated drug disposition$121,508
R01 · FY2022 · HD
Understanding Fetal Exposure to Cannabinoids Through In Vitro and In Vivo Studies$496,931
P01 · FY2021 · DA · contact PI
A Systems Pharmacology approach to predict the effects of pregnancy and infectious diseases on transporter-mediated drug disposition$429,657
R01 · FY2021 · HD
Understanding Fetal Exposure to Cannabinoids Through In Vitro and In Vivo Studies$592,531
P01 · FY2020 · DA · contact PI
Understanding Fetal Exposure to Cannabinoids Through In Vitro and In Vivo Studies$434,998
P01 · FY2019 · DA · contact PI
Placental P-gp/BCRP in fetal drug exposure and regulation by hormones/xenobiotic$312,828
P01 · FY2017 · DA · contact PI
Placental P-gp/BCRP in fetal drug exposure and regulation by hormones/xenobiotic$266,406
P01 · FY2016 · DA · contact PI
Placental P-gp/BCRP in fetal drug exposure and regulation by hormones/xenobiotic$359,971
P01 · FY2015 · DA · contact PI
Placental P-gp/BCRP in fetal drug exposure and regulation by hormones/xenobiotic$311,186
P01 · FY2014 · DA · contact PI
Placental P-gp/BCRP in fetal drug exposure and regulation by hormones/xenobiotic$232,782
P01 · FY2013 · DA · contact PI
Mechanism of Drug Transport by BCRP/ABCG2$247,436
R01 · FY2010 · GM · contact PI
Mechanism of Drug Transport by BCRP/ABCG2$249,935
R01 · FY2009 · GM · contact PI
Mechanism of Drug Transport by BCRP/ABCG2$249,935
R01 · FY2008 · GM · contact PI
Mechanism of Drug Transport by BCRP/ABCG2$249,868
R01 · FY2007 · GM · contact PI
Mechanism of Drug Transport by BCRP/ABCG2$256,575
R01 · FY2006 · GM · contact PI
BCRP in pregnancy: activity, expression and regulation$0
P50 · FY2002 · HD